IntegraDose Compounding Services LLC: Drug Recall

Recall #D-0325-2024 · 01/22/2024

Class II: Risk

Recall Details

Recall Number: D-0325-2024
Classification: Class II
Product Type: Drug
Recalling Firm: IntegraDose Compounding Services LLC
Status: Ongoing
Date Initiated: 01/22/2024
Location: Minneapolis, MN, United States
Voluntary/Mandated: Voluntary: Firm initiated
Product Quantity: 1,299 syringes

Reason for Recall

Sub-potent drug: failure to maintain potency through the duration of the labeled expiration/beyond-use date.

Product Description

Vasopressin 2 Units/2 mL in 0.9% Sodium Chloride Sterile Syringe for Injection, Concentration: 1 Unit/mL, 2 mL Syringe, Rx Only, 719 Kasota Ave SE, Minneapolis, MN, Compounded Drug Not for Resale. Office Use Only, NDC 71139-0190-1.

Distribution Pattern

Other Recalls by IntegraDose Compounding Services LLC

Class I: Dangerous 09/16/2025

Subpotent Drug: Testing revealed there was no oxytocin in the IV bag.
Class II: Risk 03/22/2024

Lack of Assurance of Sterility: leaking bags
Class II: Risk 01/12/2024

Subpotent Drug
Class II: Risk 09/17/2021

Lack of sterility assurance.
Class II: Risk 09/17/2021

Lack of sterility assurance.

View all recalls by IntegraDose Compounding Services LLC →

Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.